期刊文献+

GST-GP302融合蛋白在大肠杆菌中的表达及其抗血清的制备 被引量:2

The expression of fusion protein GST-GP302 in E.coli and its preparation of rabbit anti-serum
下载PDF
导出
摘要 目的 :在大肠杆菌中表达血小板糖蛋白GPIbα之vWF结合区(GP30 2 )与谷胱甘肽S 转移酶GST的融合蛋白并制备其抗血清。方法 :将GP30 2片断插入GST融合表达载体 pGEX 4T 1,重组载体酶切鉴定后 ,在大肠杆菌中经IPTG诱导表达获得GST GP30 2融合蛋白 ,SDS PAGE分析表达产物。包涵体经变性复性后免疫新西兰白兔 ,制备抗血清 ,ELISA、Westernblot检测重组抗原的免疫活性。结果 :重组质粒酶切鉴定表明 ,GP30 2基因已正确插入到 pGEX 4T 1中 ,经IPTG诱导后 ,表达出相对分子质量 (Mr)约为 5 90 0 0的融合蛋白 ,获得了ELISA效价为 1× 10 -5的多克隆抗体。Westernblot证明所制备的多抗可以与血小板糖蛋白特异性结合。结论 :GP30 2片断在大肠杆菌中的成功表达及制备得到的多克隆抗体 。 AIM: To express fusion protein of GST and vWf binding domain(GP302) of platelet GPⅠba in E.coli and its preparation of rabbit anti serum. METHODS: GP302 gene was inserted into pGEX 4T 1. The recombinant vector was identificated by restriction endonuclease digestion analysis. Fusion protein GST GP302 was expressed in E.coli via IPTG induction. The rabbit antibody against GST GP302 was prepared by using renatured GST GP302 as immuneogen and the specificity of polyclonal antibody was identified by Western blot. RESULTS: The restriction endonuclease digestion analysis of recombinant plasmid demonstrated that the GP302 gene had been exactly inserted into pGEX 4T 1. SDS PAGE analysis showed that the ralative molecular mass( M r) of the fusion protein was about 59 000. ELISA analysis proved that the titer of rabbit serum against GST GP302 was 10 -5 . The polyclonal antibody specifically bound to purified platelet GPIbα. CONCLUSION: The preparation of polyclonal antibody against GP302 peptide provides an usefal reagent for the detection of platelet GPIbα.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2003年第3期282-283,287,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家高技术研究发展计划 (863)资助 (No .2 0 0 1AA2 1 60 51 )
关键词 血小板GPIbα 大肠杆菌 表达 多克隆抗体 platelet GPIbα expression E.col polyclonal antibody
  • 相关文献

参考文献5

  • 1[1]Handa M, Titani K, Holland L Z, et al. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments[J]. J Biol Chem, 1986, 261: 12579-12585.
  • 2[2]Sambrook J, Fristsch EF, Manatis T. Molecularcloning,a laboratory manual[M]. 2ed. New York: Cold Spring Harbor Laboratory Press, 1989: 547.
  • 3[3]Murata M, Ware J, Ruggeri ZM. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding[J]. J Biol Chem, 1991, 266: 15474-15480.
  • 4[4]Kitaguchi T, Murata M, Iijima K, et al. Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibalpha: a potential substitute for platelet transfusion[J]. Biochem Biophys Res Commun, 1999, 261(3): 784-789.
  • 5[5]Arya M, López JA, Romo GM, et al. Measurement of the binding forces between von willebrand factor and variants of platelet glycoprotein Ib-alpha using optical tweezers[J]. Lasers in Surgery and Medicine, 2002, 30: 306-312.

同被引文献26

  • 1Barbara MD. Potential for synthetic phospholipids as partial platelet substitutes. Transfusion,1998,38(11~12):997.
  • 2Klein E, Farber S, Djersasi I, et al. The prepraration and clinical administration of lyophilized platelet material to children with acute leukemia and aplastic anemia. J Pedia, 1956, 49(5):517.
  • 3Manley M, Douglas AF, Nino Vittorio, et al. Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits. J Lab Clin Med, 1987,109 (2): 127.
  • 4Johan WH, Edouard M, Bevers, et al. Platelet activation and blood coagulation. Thromb Haemost, 2002,88(2) : 186.
  • 5Burton JL. Lipid model membranes, characterization of mixed phosppholipid vesicles. Biochemistry, 1973,12(13) :2545.
  • 6Mikaelsson M, Oswaldsson U, Jankowski MA. Measurement of factor Ⅷ activity of B-domain deleted recombinant factor Ⅷ. Semin Hematol,2001,38(2 Suppl 4) : 13.
  • 7Galan AM, Hernandez MR, Bozzo J, et al. Preparation of synthetic phospholipids promote procoagulant activity on damaged vessels: studies under flow conditions. Transfusion, 1998, 38(11) :1004.
  • 8Chao FC, Kim BK, Houranieh AM, et al. Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets. Transfusion, 1996,36(6):536.
  • 9Shimizu A, Matsushita T, Kondo T, et al. Identification of the Amino acid residues of the platelet glycoprotein I b (GP I b)essential for the von Willebrand factor binding by clustered charged-to-alanine scanning mutagenesis. J Biol Chem, 2004,279(4) : 16285.
  • 10Kitaguchi T, Murata M,Iijima K, et al. Characterization if liposomes carrying von willebrand factor-binding domain of platelet glycoprotein Ⅰ bα:a potential substitute for platelet transfusion. Biochem Biophys Res Commun,1999,261(3):784.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部